Related content

Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers

By Yin Ophelia   Bédoucha Véronique   McCulloch Tracey   Zheng Cheng   Zhou Wei   Hussaini Azra   Novick Steven  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 219-226

Springer Publishing Company

Access to resources Recommend Favorite

Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients

By Loos Walter   Wit Ronald   Freedman Steven   Dyck Kristien   Gambale Jay   Li Susie   Murphy Gail   Noort Connie   Bruijn Peter   Verweij Jaap  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 3, 2007-03 ,pp. : 407-412

Springer Publishing Company

Access to resources Recommend Favorite

Is the current perception threshold test affected by circadian changes? A study of healthy volunteers

By Tomioka Toshiya   Sawamura Shigehito   Meno Aki   Hayashida Masakazu   Arita Hideko   Hanaoka Kazuo  

The Pain Clinic, Vol. 14, Iss. 3, 2002-09 ,pp. : 213-215

Maney Publishing

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of febuxostat under fasting conditions in healthy individuals

By                

Experimental and Therapeutic Medicine, Vol. 7, Iss. 2, 2014-01 ,pp. : 393-396

Spandidos Publications

Access to resources Recommend Favorite

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

By Bolton Ann   Peng Bin   Hubert Martine   Krebs-Brown Axel   Capdeville Renaud   Keller Urs   Seiberling Michael  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 102-106

Springer Publishing Company

Access to resources Recommend Favorite